New medicines. Vol 76, No 3 (1995)
- Authors: Artemiev A.I., Astrakhanova M.M., Alekseev K.V., Kiseleva G.S., Anikina N.V., Elagina I.A., Nasybullina N.M., Prikhodko L.A., Sollogub L.V., Truckman Y.G., Usmanov U.H., Abramovich R.A., Ordzhonikidze M.K.
- Issue: Vol 76, No 3 (1995)
- Pages: 269-270
- Section: New medicines
- URL: https://journals.rcsi.science/kazanmedj/article/view/101001
- DOI: https://doi.org/10.17816/kazmj101001
- ID: 101001
Cite item
Full Text
Abstract
One of the main directions of scientific research of the Research Institute of Pharmacy is the development of new effective medicines in the form of various solutions, ointments, suppositories, tablets, granules, powders, extracts intended for the treatment of a wide variety of diseases. The need of the population for anti-inflammatory drugs is satisfied by 85%, of which 28% are domestic drugs. Therefore, in recent years, the Research Institute of Pharmacy has been intensively working to create new dosage forms of piroxicam (gel and ointment) that have minimal side effects with a maximum of therapeutic activity of anti-inflammatory action.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. I. Artemiev
Email: info@eco-vector.com
Russian Federation
M. M. Astrakhanova
Email: info@eco-vector.com
Russian Federation
K. V. Alekseev
Email: info@eco-vector.com
Russian Federation
G. S. Kiseleva
Email: info@eco-vector.com
Russian Federation
N. V. Anikina
Email: info@eco-vector.com
Russian Federation
I. A. Elagina
Email: info@eco-vector.com
Russian Federation
N. M. Nasybullina
Email: info@eco-vector.com
Russian Federation
L. A. Prikhodko
Email: info@eco-vector.com
Russian Federation
L. V. Sollogub
Email: info@eco-vector.com
Russian Federation
Y. G. Truckman
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
U. H. Usmanov
Email: info@eco-vector.com
Russian Federation
R. A. Abramovich
Email: info@eco-vector.com
Russian Federation
M. K. Ordzhonikidze
Email: info@eco-vector.com
Russian Federation
References
